Lifevantage Corp

LFVN

Lifevantage Corp

LFVN

Insider Sentiment (TTM):

Last Purchase:2026-06-15Last Sale:2026-06-03Shares Purchased (TTM):17,470Shares Sold (TTM):27,732

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:7,521,994Shares Outstanding:12,625,000Institutional Ownership Pct.:59.58%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	12	10	13	20	22	22	15	17	17	17	18	22
Accounts Receivable Net Current	2	2	2	3	3	2	3	3	2	2	3	2
Income Taxes Receivable	2	3	5	1	0	0	1	0	0	0	0	0
Inventory Net	18	19	21	21	22	17	17	15	15	15	16	16
Prepaid Expense And Other Assets Current	4	4	4	6	6	5	3	2	3	4	5	5
Assets Current	39	39	45	51	54	46	39	38	38	39	42	44
Assets Noncurrent
Property Plant And Equipment Net	7	6	6	6	7	7	7	8	8	9	9	9
Operating Lease Right Of Use Asset	7	7	8	8	9	9	9	10	9	10	10	9
Intangible Assets Net Excluding Goodwill	3	3	0	0	0	0	0	0	0	0	0	0
Goodwill	0	0	-	-	-	-	-	-	-	-	-	-
Deferred Income Tax Assets Net	5	5	2	6	7	6	5	4	5	5	5	3
Other Assets Noncurrent	1	1	1	1	1	1	1	1	0	1	0	1
Assets	62	61	62	72	77	69	61	60	61	63	67	66
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	5	5	4	5	7	6	5	6	7	6	7	4
Accrued Sales Commission Current	6	6	6	7	8	8	7	7	6	7	7	7
Accrued Income Taxes Current	-	-	-	0	-	-	-	0	-	-	-	0
Taxes Payable Current And Noncurrent	-	-	0	-	1	1	0	-	1	1	2	-
Operating Lease Liability Current	2	2	2	2	2	2	2	2	2	2	2	2
Accrued Liabilities Current	-	-	-	14	-	-	-	8	-	-	-	8
Other Accrued Liabilities Current	7	7	7	-	14	11	8	-	7	8	8	-
Liabilities Current	20	19	19	27	33	28	22	22	22	23	25	20
Operating Lease Liability Noncurrent	8	9	9	10	10	11	11	12	12	12	12	12
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	29	28	28	37	43	39	34	34	35	35	37	31
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	139	138	138	140	139	138	137	137	136	135	135	134
Retained Earnings Accumulated Deficit	-104	-103	-103	-104	-104	-106	-109	-109	-108	-107	-104	-98
Accumulated Other Comprehensive Income Loss Net Of…	-2	-2	-1	-1	-2	-2	-1	-2	-2	-1	-2	-1
Stockholders Equity	33	33	33	35	34	30	28	26	27	27	29	35
Liabilities And Stockholders Equity	62	61	62	72	77	69	61	60	61	63	67	66
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	40	40	40	40	40	40	40	40	40	40	40	40
Common Stock Shares Issued	13	13	13	12	13	13	12	13	13	13	13	13
Shares Outstanding	13	13	13	12	13	13	12	13	13	13	13	13

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.86%	-12.71%	-11.71%	-16.22%	-21.77%	-7.57%	31.17%	11.04%	9.53%	-	-	-
2025	9.40%	34.11%	95.53%	-24.49%	-36.44%	-45.96%	9.41%	6.39%	14.94%	-24.01%	-35.35%	-52.05%
2024	-11.48%	-17.01%	-20.06%	15.44%	18.95%	15.50%	23.24%	11.22%	8.76%	22.86%	39.28%	57.63%
2023	-	-	-	-	-	-	-	-	-	42.90%	46.40%	16.09%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.96	2.03	2.39	1.87	1.66	1.66	1.76	1.69	1.68	1.68	1.70	2.26
Quick Ratio	0.85	0.80	1.11	0.89	0.79	0.86	0.84	0.90	0.88	0.86	0.85	1.20
Working Capital	19.21M	19.54M	26.22M	23.68M	21.53M	18.24M	16.74M	15.34M	15.32M	15.64M	17.20M	24.68M
Leverage & Debt
Debt to Equity	0.86	0.85	0.86	1.08	1.27	1.29	1.22	1.32	1.29	1.30	1.27	0.91
Interest Coverage TTM	50.24	37.63	34.19	38.12	40.50	40.91	25.32	12.31	11.43	11.01	14.36	46.80
Debt Ratio	0.46	0.46	0.46	0.52	0.56	0.56	0.55	0.57	0.56	0.56	0.56	0.48
Efficiency & Turnover
Asset Turnover TTM	2.80	3.24	3.72	3.46	3.21	3.23	3.06	3.17	3.20	3.23	3.17	3.12
Days Sales Outstanding TTM	5.29	3.77	4.30	4.99	4.41	3.80	5.09	4.16	3.99	4.10	3.79	4.23
Receivables Turnover TTM	69.02	96.73	84.88	73.21	82.73	95.95	71.64	87.77	91.56	88.97	96.37	86.22
Per Share Metrics
Diluted EPS TTM	0.45	0.62	0.78	-	0.69	0.56	0.32	-	0.28	0.23	0.20	-
Free Cash Flow Per Share TTM	0.30	0.13	0.70	0.86	0.97	1.05	0.44	0.80	0.88	0.84	0.75	0.30
Dividend Per Share TTM	0.18	0.17	0.17	0.17	0.16	0.16	0.16	0.56	0.55	0.54	0.54	0.13
Margin Metrics
Gross Profit Margin TTM	78.14%	78.75%	80.29%	80.37%	80.29%	79.79%	79.21%	79.30%	79.32%	79.65%	79.52%	79.67%
Operating Profit Margin TTM	3.37%	4.26%	5.20%	5.34%	5.83%	5.11%	3.14%	2.16%	1.96%	1.75%	1.75%	2.00%
Net Profit Margin TTM	2.94%	3.74%	4.43%	4.29%	4.12%	3.46%	2.11%	1.47%	1.75%	1.40%	1.20%	1.19%
Growth Metrics
Net Revenue Growth (1Y)	-12.15%	-0.99%	16.77%	14.17%	8.22%	0.57%	-7.97%	-6.20%	-2.22%	2.21%	3.94%	3.41%
Net Income Growth (1Y)	-37.14%	7.08%	145.14%	233.84%	154.34%	147.89%	61.55%	15.63%	-527.32%	-509.54%	518.12%	-18.59%
EPS Growth (1Y)	-38.51%	3.43%	140.47%	239.48%	155.86%	156.03%	66.53%	16.55%	-533.89%	-507.30%	514.17%	-16.46%
Valuation Metrics
P/E TTM	9.42	9.75	11.64	15.92	19.10	28.24	34.32	26.19	19.98	24.32	29.91	19.17
P/B TTM	1.63	2.32	3.56	4.51	5.14	6.93	5.12	2.96	2.69	2.64	2.61	1.41
P/S TTM	0.28	0.36	0.52	0.68	0.79	0.98	0.72	0.38	0.35	0.34	0.36	0.23
Market Cap	54.19M	76.64M	117.93M	156.07M	174.75M	207.26M	141.86M	76.91M	71.90M	72.02M	76.54M	48.69M
Enterprise Value	41.71M	66.46M	104.84M	135.87M	152.28M	185.67M	127.27M	60.03M	54.52M	54.69M	58.14M	27.08M
Calculated Values
Free Cash Flow TTM	3.78M	1.70M	8.70M	10.51M	11.98M	12.88M	5.39M	9.95M	10.90M	10.55M	9.47M	3.76M
Net Debt	-12.48M	-10.18M	-13.09M	-20.20M	-22.47M	-21.60M	-14.60M	-16.89M	-17.38M	-17.33M	-18.41M	-21.61M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Purchase

Owner: Lewis, Darwin

Title: -

Shares: 705

Price/Share: $8.60

Value: $6,063.00

Shares Owned: 137,268

Relationship: Director

Ownership: Direct

2026-06-03Sale

Owner: Beindorff, Michael A

Title: -

Shares: 10,000

Price/Share: $8.55

Value: $85,500.00

Shares Owned: 41,625

Relationship: Director

Ownership: Indirect

2026-03-16Purchase

Owner: Lewis, Darwin

Title: -

Shares: 1,055

Price/Share: $5.23

Value: $5,517.65

Shares Owned: 136,563

Relationship: Director

Ownership: Direct

2026-03-02Purchase

Owner: Dayton, Judd

Title: -

Shares: 10,500

Price/Share: $4.53

Value: $47,565.00

Shares Owned: 80,359

Relationship: Director

Ownership: Direct

2026-02-09Purchase

Owner: Lewis, Darwin

Title: -

Shares: 3,955

Price/Share: $5.22

Value: $20,645.10

Shares Owned: 135,508

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Lewis, Darwin	Director	-	Direct	Purchase	705	8.60	$6,063.00	137,268	4
2026-06-03	Beindorff, Michael A	Director	-	Indirect	Sale	10,000	8.55	$85,500.00	41,625	4
2026-03-16	Lewis, Darwin	Director	-	Direct	Purchase	1,055	5.23	$5,517.65	136,563	4
2026-03-02	Dayton, Judd	Director	-	Direct	Purchase	10,500	4.53	$47,565.00	80,359	4
2026-02-09	Lewis, Darwin	Director	-	Direct	Purchase	3,955	5.22	$20,645.10	135,508	4
2025-12-15	Lewis, Darwin	Director	-	Direct	Purchase	805	6.54	$5,264.70	131,553	4
2025-11-19	Beindorff, Michael A	Director	-	Indirect	Sale	12,607	6.42	$80,936.94	43,806	4
2025-11-07	Beindorff, Michael A	Director	-	Direct	Sale	1,000	7.33	$7,330.00	35,389	4
2025-09-16	Lewis, Darwin	Director	-	Direct	Purchase	450	10.85	$4,882.50	117,217	4
2025-09-09	Beindorff, Michael A	Director	-	Direct	Sale	4,125	11.44	$47,190.00	22,858	4
2025-07-01	Aure, Carl	Officer	Chief Financial Officer	Direct	Sale	2,746	13.39	$36,768.94	133,303	4
2025-06-13	Lewis, Darwin	Director	-	Direct	Purchase	379	12.82	$4,858.78	116,767	4
2025-05-09	Mauro, Garry Paul	Director	-	Direct	Purchase	601	12.25	$7,362.25	86,087	4
2025-02-10	Greer, Raymond B	Director	-	Direct	Sale	8,000	20.15	$161,200.00	99,288	4
2025-02-10	Beindorff, Michael A	Director	-	Direct	Sale	5,850	19.54	$114,309.00	44,168	4
2025-02-10	Latham, Cynthia	Director	-	Direct	Sale	4,450	20.02	$89,089.00	51,348	4
2024-12-16	Lewis, Darwin	Director	-	Direct	Purchase	227	16.00	$3,632.00	116,388	4
2024-09-17	Lewis, Darwin	Director	-	Direct	Purchase	351	10.27	$3,604.77	108,342	4
2024-09-03	Mauro, Garry Paul	Director	-	Direct	Purchase	600	7.41	$4,446.00	77,667	4
2024-06-14	Lewis, Darwin	Director	-	Direct	Purchase	489	7.37	$3,603.93	107,991	4
2024-03-15	Lewis, Darwin	Director	-	Direct	Purchase	449	6.97	$3,129.53	107,502	4
2024-02-02	Mauro, Garry Paul	Director	-	Direct	Purchase	162	5.66	$916.92	77,067	4
2023-12-15	Lewis, Darwin	Director	-	Direct	Purchase	460	6.83	$3,141.80	107,053	4
2023-11-20	Beindorff, Michael A	Director	-	Indirect	Sale	5,500	6.00	$33,000.00	54,798	4
2023-11-16	Mauro, Garry Paul	Director	-	Direct	Purchase	4,970	4.75	$23,607.50	71,183	4
2023-09-22	Lewis, Darwin	Director	-	Direct	Purchase	4,124	6.94	$28,620.56	89,408	4
2023-09-05	Mauro, Garry Paul	Director	-	Direct	Purchase	425	7.63	$3,242.75	64,189	4
2023-08-25	Sudbury, Capital Gp, Lp, …	Other	-	Indirect	Purchase	5,490	4.95	$27,175.50	749,325	4
2023-08-11	Radoff, Family Foundation…	Other	-	Indirect	Purchase	20,000	5.07	$101,400.00	50,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

59.58%

Inst. Shares: 7,521,994

Shares Outstanding: 12,625,000

2025-12-31

59.18%

Inst. Shares: 7,482,372

Shares Outstanding: 12,643,000

2025-09-30

58.11%

Inst. Shares: 7,204,751

Shares Outstanding: 12,398,000

2025-06-30

57.51%

Inst. Shares: 7,045,029

Shares Outstanding: 12,251,000

2025-03-31

48.92%

Inst. Shares: 6,041,180

Shares Outstanding: 12,350,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	7,521,994	12,625,000	59.58%
2025-12-31	7,482,372	12,643,000	59.18%
2025-09-30	7,204,751	12,398,000	58.11%
2025-06-30	7,045,029	12,251,000	57.51%
2025-03-31	6,041,180	12,350,000	48.92%
2024-12-31	3,859,171	12,211,000	31.60%
2024-09-30	3,542,005	12,162,000	29.12%
2024-06-30	2,602,022	12,458,000	20.89%
2024-03-31	1,738,994	12,424,000	14.00%
2023-12-31	1,709,248	12,612,000	13.55%
2023-09-30	1,782,263	12,537,000	14.22%
2023-06-30	1,769,440	12,557,000	14.09%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Lifevantage Corp (LFVN) — SEC Financial Statements & Analysis

Lifevantage Corp (LFVN) is a pharmaceutical preparations company. Lifevantage Corp trades on Nasdaq as: LFVN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Lifevantage Corp reported a -12.15% year-over-year revenue growth, a Gross Profit Margin of 78.14% (TTM), a Debt-to-Equity ratio of 0.86x, a Price-to-Sales (P/S) ratio of 0.28x (TTM), a Price-to-Book (P/B) ratio of 1.63x (TTM), at a market cap of $54.19M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -12.15%
Gross Profit Margin TTM: 78.14%
Debt To Equity: 0.86x
P/S TTM: 0.28x
P/B TTM: 1.63x
Market Cap: $54.19M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Lifevantage Corp in?

Lifevantage Corp (LFVN) operates in the Pharmaceutical Preparations industry.

What is LFVN's market cap?

Lifevantage Corp (LFVN) has a market capitalization of $54.19M as of 2026-03-31.

What is LFVN's P/E ratio?

Lifevantage Corp (LFVN)'s trailing twelve month P/E ratio is 9.42x as of 2026-03-31.

What exchange does LFVN trade on?

Lifevantage Corp (LFVN) trades on the Nasdaq.